Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: Mol Pharm. 2011 Jun 20;8(4):1381–1389. doi: 10.1021/mp2002076

Figure 5.

Figure 5

MCL-1expression at protein level 48 h after A549 cells were transfected with pre-miR-133b NeoFX complexes, pre-miR-133b containing lipoplexes, pre-miR-NC NeoFX complexes and pre-miR-NC containing lipoplexes at pre-miR concentration of 100 nM. Compared with untreated cells, MCL-1 protein expression was downregulated 56.2% by pre-miR-133b containing lipoplexes and 31.7% by pre-miR-133b NeoFX complexes. No significant difference at p < 0.05 level was observed between untreated cells and cells treated by pre-miR-NC containing lipoplexes and pre-miR-NC NeoFX complexes (LP, lipo-plexes; *, p < 0.05; n = 3).